Biotech / Life Sciences

Portfolio

Cutiss is a Swiss clinical-stage life-science company that provides patients with acute scarring (especially due to burns, trauma and operations) with bio-engineered, customised human skin (their trademarked “denovoSkin”).

Visit Website

ImmonuPhotonics is a biotechnology company that is developing a proprietary treatment for solid-tumour cancers. The company is headquartered in St Louis, Missouri, USA, with subsidiaries in Bern, Switzerland, and Tianjin, China.

Visit Website

Scipio Bioscience is developing and industrialising a first sample preparation kit, designed to democratise single-cell sequencing experiments.

Visit Website

PathoQuest enables screening for more than 1,200 pathogens with a single test instead of the multiple tests currently required, assisting with the rapid diagnosis of infectious diseases.

Visit Website

Biograil’s novel technology allows for the oral delivery of injectable pharmaceutical products.

Visit Website

Latest News Articles

AngioDynamics and Immunophotonics Announces Partnership to Explore the Power of Immunotherapy

AngioDynamics, Inc. (NASDAQ: ANGO) and Immunophotonics, Inc. are pleased to announce a partnership that will combine use of Imm

Read more >

CUTISS announces positive Phase 2 clinical trial results for denovoSkin™

CUTISS AG has announced positive results from the Phase 2 clinical trial of its lead product denovoSkin™, in adult and adoles

Read more >

CUTISS launches Series C financing round to advance the development of its personalized skin technology

CUTISS seeks to raise the Series C with the participation of existing and new investors to take its personalized skin therapy d

Read more >